Quick Answer
Cadrenal Therapeutics, Inc. reported Total Assets of $4.33 million for the year ending 2025.
- Cadrenal Therapeutics, Inc. showed a decrease of -57.3% in Total Assets from 2024 to 2025.
- This data is from Cadrenal Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: $4.48 million | Q2 2023: $3.56 million | Q3 2023: $9.31 million | Q1 2024: $7.05 million | Q2 2024: $5.46 million | Q3 2024: $4.68 million | Q1 2025: $7.95 million | Q2 2025: $5.98 million | Q3 2025: $4.09 million.
- Over the full 4 years of available data (2022 to 2025), Cadrenal Therapeutics, Inc.'s Total Assets has grown by 456.0%.
- Historical annual values: Fiscal year 2025: $4.33 million | Fiscal year 2024: $10.12 million | Fiscal year 2023: $8.52 million | Fiscal year 2022: $778.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: